These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3078804)

  • 1. A neurologist looks at neurological disease temporally related to DTP immunization.
    Stephenson JB
    Tokai J Exp Clin Med; 1988; 13 Suppl():157-64. PubMed ID: 3078804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permanent brain damage and pertussis vaccination: is the end of the saga in sight?
    Griffith AH
    Vaccine; 1989 Jun; 7(3):199-210. PubMed ID: 2571213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diphtheria-tetanus-pertussis vaccine and serious neurologic illness: an updated review of the epidemiologic evidence.
    Wentz KR; Marcuse EK
    Pediatrics; 1991 Mar; 87(3):287-97. PubMed ID: 2000268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe reactions associated with diphtheria-tetanus-pertussis vaccine: detailed study of children with seizures, hypotonic-hyporesponsive episodes, high fevers, and persistent crying.
    Blumberg DA; Lewis K; Mink CM; Christenson PD; Chatfield P; Cherry JD
    Pediatrics; 1993 Jun; 91(6):1158-65. PubMed ID: 8502521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of serious acute neurological illness after immunization with diphtheria-tetanus-pertussis vaccine. A population-based case-control study.
    Gale JL; Thapa PB; Wassilak SG; Bobo JK; Mendelman PM; Foy HM
    JAMA; 1994 Jan; 271(1):37-41. PubMed ID: 7903109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events following immunization with DTP vaccine.
    Stetler HC; Mullen JR; Brennan JP; Orenstein WA; Bart KJ; Hinman AR
    Dev Biol Stand; 1985; 61():411-21. PubMed ID: 3879686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of seizures and encephalopathy after immunization with the diphtheria-tetanus-pertussis vaccine.
    Griffin MR; Ray WA; Mortimer EA; Fenichel GM; Schaffner W
    JAMA; 1990 Mar 23-30; 263(12):1641-5. PubMed ID: 2308203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurologic manifestations of diphtheria and pertussis.
    Sanghi V
    Handb Clin Neurol; 2014; 121():1355-9. PubMed ID: 24365424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pertussis vaccine and whooping cough as risk factors in acute neurological illness and death in young children.
    Miller D; Wadsworth J; Diamond J; Ross E
    Dev Biol Stand; 1985; 61():389-94. PubMed ID: 3879684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis immunisation and serious acute neurological illness in children.
    Miller DL; Ross EM; Alderslade R; Bellman MH; Rawson NS
    Br Med J (Clin Res Ed); 1981 May; 282(6276):1595-9. PubMed ID: 6786580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infants and children with convulsions and hypotonic-hyporesponsive episodes following diphtheria-tetanus-pertussis immunization: follow-up evaluation.
    Baraff LJ; Shields WD; Beckwith L; Strome G; Marcy SM; Cherry JD; Manclark CR
    Pediatrics; 1988 Jun; 81(6):789-94. PubMed ID: 3259305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pertussis immunisation and serious acute neurological illnesses in children.
    Miller D; Madge N; Diamond J; Wadsworth J; Ross E
    BMJ; 1993 Nov; 307(6913):1171-6. PubMed ID: 7504540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe neurological illness: further analyses of the British National Childhood Encephalopathy Study.
    Miller D; Wadsworth J; Ross E
    Tokai J Exp Clin Med; 1988; 13 Suppl():145-55. PubMed ID: 3273614
    [No Abstract]   [Full Text] [Related]  

  • 14. Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group.
    Schmitt-Grohé S; Stehr K; Cherry JD; Heininger U; Uberall MA; Laussucq S; Eckhardt T
    Dev Biol Stand; 1997; 89():113-8. PubMed ID: 9272341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurologic complications after vaccination against diphtheria, tetanus and whooping cough].
    Skovránková J; Komárek V; Domorázková E
    Cesk Pediatr; 1992 Feb; 47(2):122-4. PubMed ID: 1572012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group.
    Uberall MA; Stehr K; Cherry JD; Heininger U; Schmitt-Grohé S; Laussucq S; Eckhardt T
    Dev Biol Stand; 1997; 89():83-9. PubMed ID: 9272335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures. Recommendations of the Immunization Practices Advisory committee (ACIP).
    MMWR Recomm Rep; 1991 Aug; 40(RR-10):1-28. PubMed ID: 1865873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute encephalopathy and chronic neurological damage after pertussis vaccine.
    Cowan LD; Griffin MR; Howson CP; Katz M; Johnston RB; Shaywitz BA; Fineberg HV
    Vaccine; 1993 Nov; 11(14):1371-9. PubMed ID: 7906066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events following pertussis and rubella vaccines. Summary of a report of the Institute of Medicine.
    Howson CP; Fineberg HV
    JAMA; 1992 Jan; 267(3):392-6. PubMed ID: 1727962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.